share_log

Ardelyx | 4: Statement of changes in beneficial ownership of securities-Officer Williams Laura A

SEC announcement ·  Feb 22 16:58
Summary by Moomoo AI
Ardelyx, Inc.'s Chief Medical Officer, Laura A. Williams, completed a sale of company stock on February 20, 2024. The transaction involved 4,803 shares of Ardelyx common stock at a price of $8.7463 per share, resulting in a total sale value of $42,008.48. Following the sale, Williams holds a total of 380,138 Ardelyx shares directly. The sale was conducted in the open market.
Ardelyx, Inc.'s Chief Medical Officer, Laura A. Williams, completed a sale of company stock on February 20, 2024. The transaction involved 4,803 shares of Ardelyx common stock at a price of $8.7463 per share, resulting in a total sale value of $42,008.48. Following the sale, Williams holds a total of 380,138 Ardelyx shares directly. The sale was conducted in the open market.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more